Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He, Robert M. Witwicki, Doris P. Tabassum, Justin M. Roberts, Michalina Janiszewska, Sung Jin Huh, Yi Liang, Jeremy Ryan, Ernest Doherty, Hisham Mohammed, Hao Guo, Daniel G. Stover, Muhammad B. Ekram, Guillermo Peluffo, Jonathan Brown, Clive D'Santos, Ian E. Krop, Deborah DillonMichael McKeown, Christopher Ott, Jun Qi, Min Ni, Prakash K. Rao, Melissa Duarte, Shwu Yuan Wu, Cheng Ming Chiang, Lars Anders, Richard A. Young, Eric P. Winer, Antony Letai, William T. Barry, Jason S. Carroll, Henry W. Long, Myles Brown, X. Shirley Liu, Clifford A. Meyer, James E. Bradner, Kornelia Polyak

Research output: Contribution to journalArticlepeer-review

289 Scopus citations

Fingerprint

Dive into the research topics of 'Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences